Clinical Trial Detail

NCT ID NCT00976573
Title Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Recruitment Completed
Gender both
Phase
Variant Requirements no
Sponsors North Central Cancer Treatment Group
Indications

melanoma

Therapies

Everolimus

Bevacizumab

Age Groups: adult

No variant requirements are available.